What happened to the coxibs on the way to the cardiologist?
Alberts
David S
DS
Potter
John D
JD
Martinez
Maria Elena
ME
Hess
Lisa M
LM
Stopeck
Alison
A
Lance
Peter
P
D002309:Cardiology / Q000639:trends; D002986:Clinical Trials as Topic; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D017277:Drug Approval; D006801:Humans; D007783:Lactones / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D011358:Product Surveillance, Postmarketing; D013450:Sulfones / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D014481:United States
D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib